Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...
Maeva launches GLP-1-focused nutrition system for weight loss support
US direct-to-consumer metabolic wellness brand, Maeva, has launched a nutrition system designed to support individuals using GLP-1 weight-loss medications, as adoption of the drugs continues to rise.
GLP-1 drugs begin to reshape food demand, forcing F&B firms to rethink the basket
As appetite-suppressing GLP-1 medications gain traction, new research from Cornell University suggests measurable shifts in food purchasing are emerging.
Weight-loss drugs: What happens to the food industry when appetite disappears?
Tom Ellis, CEO and co-owner at Brand Genetics, explains how the latest surge of weight-loss drugs is disrupting consumption and what’s next for producers.
Oikos Fusion launch: Exclusive interview with Rafael Acevedo, president of yogurt at Danone North America
FoodBev caught up with Rafael Acevedo, Danone’s president of yogurt, to find out more about the rising trends behind the brand's new 'first-of-its-kind' innovation.
GLP-1 alternative beverage aims to help consumers manage stress-related snacking
Ozzi, a new wellness brand based in the US, has introduced a natural drink designed to provide an alternative to GLP-1 medications, formulated to support evening appetite control.
